Gradient Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20M | Buy |
468,335
+211,067
| +82% | +$11.5M | 0.28% | 112 |
|
|
2026
Q1 | $16.1M | Buy |
257,268
+23,007
| +10% | +$1.84M | 0.25% | 119 |
|
|
2025
Q4 | $22.3M | Buy |
234,261
+3,889
| +2% | +$381K | 0.35% | 86 |
|
|
2025
Q3 | $22.5M | Buy |
230,372
+11,958
| +5% | +$1.24M | 0.38% | 85 |
|
|
2025
Q2 | $23.5M | Sell |
218,414
-5,961
| -3% | -$603K | 0.43% | 80 |
|
|
2025
Q1 | $22.6M | Buy |
224,375
+7,476
| +3% | +$753K | 0.46% | 74 |
|
|
2024
Q4 | $19.4M | Sell |
216,899
-4,817
| -2% | -$424K | 0.39% | 76 |
|
|
2024
Q3 | $18.6M | Sell |
221,716
-63,775
| -22% | -$5.03M | 0.39% | 74 |
|
|
2024
Q2 | $22M | Buy |
285,491
+3,467
| +1% | +$254K | 0.49% | 62 |
|
|
2024
Q1 | $19.3M | Sell |
282,024
-6,519
| -2% | -$419K | 0.45% | 60 |
|
|
2023
Q4 | $16.7M | Buy |
288,543
+30,015
| +12% | +$1.6M | 0.4% | 86 |
|
|
2023
Q3 | $13.7M | Buy |
258,528
+17,071
| +7% | +$895K | 0.36% | 99 |
|
|
2023
Q2 | $13.1M | Buy |
241,457
+5,600
| +2% | +$292K | 0.34% | 103 |
|
|
2023
Q1 | $11.8M | Sell |
235,857
-55,583
| -19% | -$2.62M | 0.32% | 105 |
|
|
2022
Q4 | $13.5M | Sell |
291,440
-161,174
| -36% | -$6.98M | 0.43% | 86 |
|
|
2022
Q3 | $17.5M | Sell |
452,614
-74,288
| -14% | -$2.98M | 0.54% | 40 |
|
|
2022
Q2 | $19.6M | Buy |
526,902
+123,572
| +31% | +$5.03M | 0.57% | 33 |
|
|
2022
Q1 | $17.9M | Sell |
403,330
-42,674
| -10% | -$1.85M | 0.46% | 49 |
|
|
2021
Q4 | $18.9M | Buy |
446,004
+114,044
| +34% | +$4.79M | 0.48% | 44 |
|
|
2021
Q3 | $14.4M | Buy |
331,960
+44,627
| +16% | +$1.97M | 0.4% | 49 |
|
|
2021
Q2 | $12.3M | Buy |
287,333
+248,163
| +634% | +$10.4M | 0.36% | 61 |
|
|
2021
Q1 | $1.51M | Sell |
39,170
-104,694
| -73% | -$3.96M | 0.05% | 169 |
|
|
2020
Q4 | $5.5M | Sell |
143,864
-1,659
| -1% | -$59.8K | 0.23% | 93 |
|
|
2020
Q3 | $5.56M | Sell |
145,523
-24,953
| -15% | -$962K | 0.23% | 93 |
|
|
2020
Q2 | $5.99M | Buy |
170,476
+55,116
| +48% | +$1.98M | 0.27% | 92 |
|
|
2020
Q1 | $3.76M | Buy |
115,360
+34,334
| +42% | +$1.34M | 0.2% | 103 |
|
|
2019
Q4 | $3.66M | Buy |
+81,026
| New | +$3.39M | 0.16% | 102 |
|
|
2019
Q3 | – | Sell |
-33
| Closed | -$1K | – | 1111 |
|
|
2019
Q2 | $1K | Buy |
+33
| New | +$1.27K | ﹤0.01% | 928 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$3K | – | 993 |
|
|
2018
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 766 |
|
|
2017
Q4 | $2K | Buy |
+100
| New | +$2.76K | ﹤0.01% | 795 |
|
|
2015
Q3 | – | Sell |
-80
| Closed | -$1K | – | 598 |
|
|
2015
Q2 | $1K | Sell |
80
-280
| -78% | -$5K | ﹤0.01% | 554 |
|
|
2015
Q1 | $6K | Buy |
+360
| New | +$5.69K | ﹤0.01% | 460 |
|
Other funds holding BSX
Gradient Investments's BSX Position: Q2 2026 in Review
Gradient Investments increased its Boston Scientific (BSX) stake by 82% in Q2 2026, buying an estimated $11.5M and bringing the position to 468,335 shares worth $20M. The position accounts for 0.28% of the portfolio, ranked #112.
Gradient Investments first reported a position in BSX in Q1 2015 and has held it in 32 quarters since. The position peaked at $23.5M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Gradient Investments held 468,335 shares of Boston Scientific worth $20M as of Q2 2026.
- Gradient Investments bought 211,067 Boston Scientific shares in Q2 2026, an estimated $11.5M.
- Boston Scientific made up 0.28% of Gradient Investments's portfolio in Q2 2026, its #112 holding.
- Gradient Investments first reported a position in Boston Scientific in Q1 2015 and has held it in 32 quarters since.
- Gradient Investments's Boston Scientific position peaked at $23.5M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.